The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of eligibility criteria in advanced urothelial cancer (aUC) trials based on ASCO-FCR recommendations.
 
Daniela V. Castro
No Relationships to Disclose
 
Matthew I. Feng
No Relationships to Disclose
 
Sweta R. Prajapati
No Relationships to Disclose
 
Elyse H. Chan
No Relationships to Disclose
 
Kyle O. Lee
No Relationships to Disclose
 
Ishaan Sehgal
No Relationships to Disclose
 
Jalen Patel
No Relationships to Disclose
 
Anna O'Dell
No Relationships to Disclose
 
Zeynep Busra Zengin
No Relationships to Disclose
 
Xiaochen Li
No Relationships to Disclose
 
Alex Chehrazi-Raffle
No Relationships to Disclose
 
Nazli Dizman
Consulting or Advisory Role - Vivreon Biosciences
 
Abhishek Tripathi
Honoraria - Cardinal Health; Targeted Oncology; Urology times
Consulting or Advisory Role - Deka Biosciences; EMD Serono; Exelixis; Exelixis; Foundation Medicine; Genzyme; Pfizer; Seagen
Research Funding - Aravive (Inst); Bayer (Inst); Bayer (Inst); Clovis Oncology (Inst); Corvus Pharmaceuticals (Inst); EMD Serono (Inst); Exact Sciences (Inst); Exelixis (Inst); Pfizer (Inst); WindMIL (Inst)
 
Adam Rock
Stock and Other Ownership Interests - Bristol Myers Squibb; Cigna; Merck
 
Sandy Liu
Honoraria - Eisai; EMD Serono; Exelixis; Merck; Seagen; Seagen
Consulting or Advisory Role - Exelixis; Exelixis; Seagen; Seagen; Seagen
Speakers' Bureau - EMD Serono; Exelixis; Exelixis; Seagen
 
Benjamin D. Mercier
No Relationships to Disclose
 
Luis A Meza
No Relationships to Disclose
 
Errol James Philip
No Relationships to Disclose
 
Tanya B. Dorff
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Exelixis; Janssen Oncology; Pfizer; Seagen
Research Funding - Pfizer (Inst)
 
Sumanta Monty Pal
Research Funding - Allogene Therapeutics (Inst); crispr therapeutics (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - crispr therapeutics; Roche